share_log

先聲藥業:自願公告 - 注射用SIM0500(人源化GPRC5D-BCMA-CD3三特異性抗體)獲授美國食品藥品監督管理局快速通道資格

SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) WAS GRANTED U.S. FDA FAST TRACK DESIGNATION

Hong Kong Stock Exchange ·  Apr 9 09:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more